These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33581019)

  • 41. New Strategies in Neurogenic Heterotopic Ossification.
    Ampadiotaki MM; Evangelopoulos DS; Pallis D; Vlachos C; Vlamis J; Evangelopoulos ME
    Cureus; 2021 Apr; 13(4):e14709. PubMed ID: 34055549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early local delivery of vancomycin suppresses ectopic bone formation in a rat model of trauma-induced heterotopic ossification.
    Seavey JG; Wheatley BM; Pavey GJ; Tomasino AM; Hanson MA; Sanders EM; Dey D; Moss KL; Potter BK; Forsberg JA; Qureshi AT; Davis TA
    J Orthop Res; 2017 Nov; 35(11):2397-2406. PubMed ID: 28390182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of Bone and Muscle Injuries on the Osteogenic Potential of Muscle Progenitors: Contribution of Tissue Environment to Heterotopic Ossification.
    Molligan J; Mitchell R; Schon L; Achilefu S; Zahoor T; Cho Y; Loube J; Zhang Z
    Stem Cells Transl Med; 2016 Jun; 5(6):745-53. PubMed ID: 27112178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beliefs relating to recurrence of heterotopic ossification following excision in patients with spinal cord injury: a review.
    Genêt F; Ruet A; Almangour W; Gatin L; Denormandie P; Schnitzler A
    Spinal Cord; 2015 May; 53(5):340-4. PubMed ID: 25687517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustained local ionic homeostatic imbalance caused by calcification modulates inflammation to trigger heterotopic ossification.
    Bohner M; Maazouz Y; Ginebra MP; Habibovic P; Schoenecker JG; Seeherman H; van den Beucken JJJP; Witte F
    Acta Biomater; 2022 Jun; 145():1-24. PubMed ID: 35398267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterotopic ossification after central nervous system trauma: A current review.
    Sullivan MP; Torres SJ; Mehta S; Ahn J
    Bone Joint Res; 2013 Mar; 2(3):51-7. PubMed ID: 23610702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocytes Are Not Required for Neurogenic Heterotopic Ossification Development after Spinal Cord Injury.
    Alexander KA; Tseng HW; Kulina I; Fleming W; Vaquette C; Genêt F; Ruitenberg MJ; Lévesque JP
    Neurotrauma Rep; 2022; 3(1):87-96. PubMed ID: 35317305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges of heterotopic ossification-Molecular background and current treatment strategies.
    Łęgosz P; Drela K; Pulik Ł; Sarzyńska S; Małdyk P
    Clin Exp Pharmacol Physiol; 2018 Dec; 45(12):1229-1235. PubMed ID: 30144316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical Excision of Heterotopic Ossification Leads to Re-Emergence of Mesenchymal Stem Cell Populations Responsible for Recurrence.
    Agarwal S; Loder S; Cholok D; Li J; Breuler C; Drake J; Brownley C; Peterson J; Li S; Levi B
    Stem Cells Transl Med; 2017 Mar; 6(3):799-806. PubMed ID: 28297577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurogenic heterotopic ossification in spinal cord injury.
    van Kuijk AA; Geurts AC; van Kuppevelt HJ
    Spinal Cord; 2002 Jul; 40(7):313-26. PubMed ID: 12080459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Union Rates and Reported Range of Motion Are Acceptable After Open Forearm Fractures in Military Combatants.
    Nappo KE; Hoyt BW; Balazs GC; Nanos GP; Ipsen DF; Tintle SM; Polfer EM
    Clin Orthop Relat Res; 2019 Apr; 477(4):813-820. PubMed ID: 30811353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurogenic Heterotopic Ossifications Develop Independently of Granulocyte Colony-Stimulating Factor and Neutrophils.
    Tseng HW; Kulina I; Salga M; Fleming W; Vaquette C; Genêt F; Levesque JP; Alexander KA
    J Bone Miner Res; 2020 Nov; 35(11):2242-2251. PubMed ID: 32568412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies.
    Wong KR; Mychasiuk R; O'Brien TJ; Shultz SR; McDonald SJ; Brady RD
    Bone Res; 2020 Dec; 8(1):42. PubMed ID: 33298867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications.
    Torossian F; Guerton B; Anginot A; Alexander KA; Desterke C; Soave S; Tseng HW; Arouche N; Boutin L; Kulina I; Salga M; Jose B; Pettit AR; Clay D; Rochet N; Vlachos E; Genet G; Debaud C; Denormandie P; Genet F; Sims NA; Banzet S; Levesque JP; Lataillade JJ; Le Bousse-Kerdilès MC
    JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients].
    Wang YK; Sun WF; Liu XG; Deng J; Yan BE; Jiang WY; Lin XB
    Zhongguo Gu Shang; 2011 May; 24(5):399-403. PubMed ID: 21688537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum-mediated osteogenic effect in traumatic brain-injured patients.
    Gautschi OP; Cadosch D; Frey SP; Skirving AP; Filgueira L; Zellweger R
    ANZ J Surg; 2009 Jun; 79(6):449-55. PubMed ID: 19566868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Awareness of Heterotopic Ossification in Total Joint Arthroplasty: A Primer.
    Lespasio MJ; Guarino AJ
    Perm J; 2020; 24():. PubMed ID: 32069212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for developing heterotopic ossification in patients with traumatic brain injury.
    Dizdar D; Tiftik T; Kara M; Tunç H; Ersöz M; Akkuş S
    Brain Inj; 2013; 27(7-8):807-11. PubMed ID: 23730889
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness of Prophylactic Interventions in Neurogenic Heterotopic Ossification (NHO): A Systematic Review.
    Rizvi SMHA; Sharaf J; Williams KD; Tariq M; Acharekar MV; Guerrero Saldivia SE; Unnikrishnan S; Chavarria YY; Akindele AO; Jalkh AP; Eastmond AK; Shetty C; Mohammed L
    Cureus; 2022 Aug; 14(8):e27683. PubMed ID: 36072216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial.
    Pacifici M
    Bone; 2018 Apr; 109():267-275. PubMed ID: 28826842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.